Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Chronic Progressive

Explore clinical trials studying Multiple Sclerosis, Chronic Progressive. Study availability and eligibility vary by location and protocol.

186 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Chronic Progressive trial results

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis

NCT04035005

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • MS and Neuromuscular Center of Excellence Clearwater, Florida, United States
  • Neurological Services of Orlando Orlando, Florida, United States
  • Vero Neurology Vero Beach, Florida, United States
View all 155 locations
View Trial Details
Active, not recruiting

ABA-101 in Participants With Progressive Multiple Sclerosis

NCT06566261

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Rutgers, Robert Wood Johnson Medical School New Brunswick, New Jersey, United States
  • Cleveland Clinic Mellen Center Cleveland, Ohio, United States
View Trial Details
Active, not recruiting

Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration

NCT05893225

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +16 more
Locations
  • AZ Sint-Jan Brugge Bruges, Belgium
  • Antwerp University Hospital Edegem, Belgium
  • University Hospital Ghent Ghent, Belgium
  • National MS Center Melsbroek Melsbroek, Belgium
View Trial Details
Completed

Novel Imaging Markers in SPMS

NCT05357833

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • University of Utah Health Imaging and Neurosciences Center Salt Lake City, Utah, United States
View Trial Details
Completed

A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis

NCT05232825

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • Neurology Associates PA Maitland, Florida, United States
  • University of South Florida Tampa, Florida, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis Owosso, Michigan, United States
View all 37 locations
View Trial Details

Related conditions